Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label

被引:14
作者
Dutta, AK [1 ]
Fei, XS
Vaughan, RA
Gaffaney, JD
Wang, NN
Lever, JR
Reith, MEA
机构
[1] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA
[2] Univ N Dakota, Sch Med, Dept Biochem & Mol Biol, Grand Forks, ND 58202 USA
[3] Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA
[4] Univ Illinois, DBTS, Peoria, IL USA
关键词
dopamine transporter; GBR; 12909; photoaffinity ligand; structure activity relationship study;
D O I
10.1016/S0024-3205(01)00981-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The dopamine transporter (DAT) has been implicated strongly in cocaine's reinforcing effects. Many derivatives of piperidine analogs of GBR 12909 have been developed and were found to be quite potent and selective for the DAT. In this regard, most of these derivatives were found to be much more selective for the DAT than conventional GBR compounds e.g. GBR 12909 when their selectivity was compared with the serotonin transporter (SERT). A brief structure-activity relationship (SAR) study has been carried out in the development of a novel photoaffinity ligand which illustrated the effect of the presence of a sterically bulky iodine atom next to the azido group in activity and selectivity for the DAT. This SAR study also led to the development of the compound 4 which is one of the most potent and selective blockers for the DAT known today. The photoaffinity ligand [I-125]AD-96-129 was incorporated into the DAT molecule as was demonstrated by immunoprecipitation with serum 16 which is specific for DAT. This photolabeling was antagonized by DAT-specific blockers and was unaffected by specific SERT and norepinephrine transporter (NET) blockers indicating interaction of this novel ligand with the DAT. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1839 / 1849
页数:11
相关论文
共 32 条
[11]   DIFFERENTIAL RELATIONSHIPS AMONG DOPAMINE TRANSPORTER AFFINITIES AND STIMULANT POTENCIES OF VARIOUS UPTAKE INHIBITORS [J].
IZENWASSER, S ;
TERRY, P ;
HELLER, B ;
WITKIN, JM ;
KATZ, JL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 263 (03) :277-283
[12]  
JOHNSON KM, 1983, FED PROC, V42, P2579
[13]   THE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) AND ITS RELEVANCE TO PARKINSONS-DISEASE [J].
KINEMUCHI, H ;
FOWLER, CJ ;
TIPTON, KF .
NEUROCHEMISTRY INTERNATIONAL, 1987, 11 (04) :359-373
[14]   DOPAMINE TRANSPORTER SITE-DIRECTED MUTATIONS DIFFERENTIALLY ALTER SUBSTRATE TRANSPORT AND COCAINE BINDING [J].
KITAYAMA, S ;
SHIMADA, S ;
XU, HX ;
MARKHAM, L ;
DONOVAN, DM ;
UHL, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7782-7785
[15]  
KITTY JE, 1991, SCIENCE, V254, P578
[16]   NEUROTRANSMITTER UPTAKE - TOOL IN IDENTIFYING NEUROTRANSMITTER-SPECIFIC PATHWAYS [J].
KUHAR, MJ .
LIFE SCIENCES, 1973, 13 (12) :1623-1634
[17]   THE DOPAMINE HYPOTHESIS OF THE REINFORCING PROPERTIES OF COCAINE [J].
KUHAR, MJ ;
RITZ, MC ;
BOJA, JW .
TRENDS IN NEUROSCIENCES, 1991, 14 (07) :299-302
[18]   MPTP - CURRENT CONCEPTS AND CONTROVERSIES [J].
LANGSTON, JW ;
IRWIN, I .
CLINICAL NEUROPHARMACOLOGY, 1986, 9 (06) :485-507
[19]   The region of dopamine transporter encompassing the 3rd transmembrane domain is crucial for function [J].
Lee, SH ;
Kang, SS ;
Son, H ;
Lee, YS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 246 (02) :347-352
[20]  
MADRAS BK, 1989, MOL PHARMACOL, V36, P518